通过纳米粒子减少化疗/辐射诱导的心脏毒性的方法
Ketao Li1, Wan Chen2, Liping Ma1
1Department of Cardiology, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, Zhejiang, 310022, China.
Environmental research
|September 30, 2023
概括
纳米颗粒药物递送系统通过提高治疗效率和最大限度地减少心脏毒性等副作用,为彻底改变癌症治疗提供了一个有希望的方法. 进一步的研究对于开发基于纳米粒子的安全和临床可翻译的治疗方法至关重要.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 传统的癌症疗法 (化疗,放射治疗) 由于正常组织的毒性和严重的副作用,特别是心脏毒性而面临局限性.
- 纳米颗粒为向药物输送提供了独特的特性,有可能改善治疗结果并减少不良影响.
- 在优化癌症治疗方面,最大限度地减少健康组织中的药物积累,并增强瘤特异性输送是关键挑战.
研究的目的:
- 审查基于纳米粒子的药物输送在癌症治疗中的好处.
- 突出纳米颗粒在减少与癌症治疗相关的心脏毒性方面的潜力.
- 讨论基于纳米粒子的癌症治疗的挑战和未来方向.
主要方法:
- 关于纳米粒子在癌症治疗中的应用实验研究的文献综述.
- 关于纳米粒子功效和毒性的体外和体内数据的分析.
- 对基于纳米粒子的药物输送系统进行增强癌症治疗的当前研究的综合.
主要成果:
- 纳米颗粒可以显著增强瘤中的药物积累,同时最大限度地减少对健康组织 (包括心脏) 的暴露.
- 基于纳米粒子的方法显示出提高化疗和放射治疗有效性的潜力.
- 研究表明,纳米粒子可以减轻癌症治疗的心脏毒性影响.
结论:
- 基于纳米粒子的药物输送在癌症治疗中取得了重大进展,提供了更好的疗效和降低毒性.
- 解决纳米粒子毒性等挑战对于成功的临床转化至关重要.
- 开发安全有效的纳米粒子疗法对于未来的癌症护理至关重要.
相关概念视频
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
184
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
184
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K